Published in Diabetes Care on January 01, 1999
GAD antibodies in classification of Asian type 2 diabetes. Diabetes Care (1999) 0.75
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia (2006) 8.18
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia (2001) 5.79
Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia (2004) 3.26
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Rising prevalence of NIDDM in an urban population in India. Diabetologia (1997) 3.03
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Temporal changes in prevalence of diabetes and impaired glucose tolerance associated with lifestyle transition occurring in the rural population in India. Diabetologia (2004) 2.32
Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract (2003) 2.27
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care (2003) 2.18
Patients' adherence to diabetes treatment. J Assoc Physicians India (1999) 2.10
High prevalence of diabetes in an urban population in south India. BMJ (1988) 1.90
Differentiation of embryonic mesenchymal cells to odontoblast-like cells by overexpression of dentin matrix protein 1. Proc Natl Acad Sci U S A (2001) 1.85
Prevalence of overweight in urban Indian adolescent school children. Diabetes Res Clin Pract (2002) 1.80
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer (2011) 1.77
Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care (1992) 1.73
Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract (2005) 1.66
Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS). Int J Clin Pract (2009) 1.66
Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract (2006) 1.66
Incidence of IDDM in children in urban population in southern India. Madras IDDM Registry Group Madras, South India. Diabetes Res Clin Pract (1996) 1.56
Expenditure on health care incurred by diabetic subjects in a developing country--a study from southern India. Diabetes Res Clin Pract (2000) 1.55
Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry (2000) 1.54
Plasma homocysteine concentration and coronary artery disease in Asian Indians. J Assoc Physicians India (2002) 1.49
Impacts of urbanisation on the lifestyle and on the prevalence of diabetes in native Asian Indian population. Diabetes Res Clin Pract (1999) 1.48
The genetic predisposition to fibrocalculous pancreatic diabetes. Diabetologia (1989) 1.46
Global policy: aspects of diabetes in India. Health Policy (2003) 1.45
High prevalence of cardiometabolic risk factors among young physicians in India. J Assoc Physicians India (2008) 1.45
A comparative study of sialic acid-rich proteins in rat bone and dentin. Eur J Oral Sci (2001) 1.44
Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs. J Assoc Physicians India (1990) 1.40
Impact of poverty on the prevalence of diabetes and its complications in urban southern India. Diabet Med (2002) 1.40
Influence of life style factors in development of diabetes in Indians--scope for primary prevention. J Assoc Physicians India (1999) 1.39
Foot care economics--cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India (2001) 1.39
Glucagon response to glucose load in offspring of conjugal type 2 diabetic parents in south India. J Assoc Physicians India (1992) 1.36
Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care (1998) 1.33
Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract (1997) 1.28
Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract (2007) 1.28
Stress and undetected hyperglycemia in southern Indian coastal population affected by tsunami. J Assoc Physicians India (2006) 1.26
Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population. J Assoc Physicians India (2003) 1.23
Need for education on footcare in diabetic patients in India. J Assoc Physicians India (1999) 1.23
Profile of diabetic foot complications and its associated complications--a multicentric study from India. J Assoc Physicians India (2005) 1.22
Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban southern India. Diabetes Res Clin Pract (2002) 1.21
Significance of impaired glucose tolerance in an Asian Indian population: a follow-up study. Diabetes Res Clin Pract (1986) 1.18
Exenatide and acute pancreatitis. J Assoc Physicians India (2008) 1.18
Risk variables for coronary artery disease in Asian Indians. Am J Cardiol (2001) 1.17
Prevalence of childhood diabetes in an urban population in south India. Diabetes Res Clin Pract (1992) 1.16
Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem Soc Trans (2004) 1.16
Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract (2004) 1.15
Familial aggregation of type 2 (non-insulin-dependent) diabetes mellitus in south India; absence of excess maternal transmission. Diabet Med (1996) 1.14
Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab (2011) 1.11
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia (2011) 1.10
Costs incurred by families having Type 1 diabetes in a developing country--a study from Southern India. Diabetes Res Clin Pract (2002) 1.07
High prevalence of maturity-onset diabetes of the young (MODY) among Indians. Diabetes Care (1985) 1.05
High prevalence of type 2 (non-insulin-dependent) diabetes among the offspring of conjugal type 2 diabetic parents in India. Diabetologia (1985) 1.05
Comparative study of monocomponent insulins and conventional insulins on the course of diabetic nephropathy. A follow-up study. J Assoc Physicians India (1990) 1.05
Cost burden to diabetic patients with foot complications--a study from southern India. J Assoc Physicians India (2000) 1.05
Colovaginal and colovesical fistulae: the diagnostic paradigm. Tech Coloproctol (2012) 1.04
Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. J Assoc Physicians India (2002) 1.04
Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP (2001) 1.03
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia (2009) 1.02
Primary prevention of Type 2 diabetes in South Asians--challenges and the way forward. Diabet Med (2013) 1.02